-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Oyster Point Pharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2020 to Q3 2022.
- Oyster Point Pharma, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2022 was -$2.83M, a 214% decline year-over-year.
- Oyster Point Pharma, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2022 was -$18.2M.
- Oyster Point Pharma, Inc. annual Nonoperating Income (Expense) for 2021 was -$4M, a 954% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)